Silence Therapeutics PLC (LSE:SLN) - Share price - Overview

Stock Report

Silence Therapeutics PLC SLN

Last Price
GBX147.00

Day Change
-10.00|-6.37%

As of 20/07/2018
18:41:41 BST | GBX
Minimum 15 Minutes Delay.

Last Close157.00p
Day Range145.00 - 157.50
Mkt Cap103.00Mil
52-Wk Range105.75 - 254.75
Yield %-
ISINGB00B9GTXM62
Volume99,768
P/E-11.49
P/S63.91
P/CF-0.11

Share Price

Total Returns 20/07/2018

 Chg (%)  
More ...
Silence Therapeutics PLC2.08 
FTSE 100 TR GBP0.80
 
Financials
201520162017
More ...
Income Statement
Turnover0.000.770.02
Operating Profit-9.77-11.91-14.39
Net Profit-6.65-8.44-1.62
Reported EPS-10.40-12.10-2.30
Balance Sheet
Current Assets53.5542.0145.55
Non Current Assets8.0013.789.46
Total Assets61.5555.7955.01
Current Liabilities1.121.612.66
Total Liabilities1.121.612.66
Total Equity60.4354.1852.35
Cash Flow
Operating Cash Flow-8.26-11.66-11.61
Net Change in Cash35.22-14.843.46
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
02/08/2017PurchaseAlistair William Gray MA,IOM129.753,8484,993.00
31/07/2017PurchaseDr. Andrew John McGlashan Richards CBE146.887,00010,282.00

Company Profile

Silence Therapeutics PLC is a biotechnology company in the United Kingdom. It uses its RNA technology to develop drugs to address genetic disorders.

Sector

Biotechnology

Index

FTSE AIM All-Share

Next Event 06/09/2018

Half-Yearly Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-7.18
Op Mrgn-899.44
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive DirectorDr. Andrew John McGlashan Richards CBE
Non-Executive DirectorAlistair William Gray MA,IOM
Non-Executive DirectorDr. Stephen Barry Parker
Executive Director, Chief Executive OfficerAli Mortazavi
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.